Studying Neuronal Differentiation in Neuroblastoma Using Anti-MYCN shRNA
Author Information
Author(s): Henriksen Jørn R, Haug Bjørn Helge, Buechner Jochen, Tømte Ellen, Løkke Cecilie, Flaegstad Trond, Einvik Christer
Primary Institution: University Hospital of North-Norway
Hypothesis
Can retrovirally delivered anti-MYCN shRNA induce neuronal differentiation in MYCN-amplified neuroblastoma cell lines?
Conclusion
The study developed an effective model to knock down MYCN and promote neuronal differentiation in neuroblastoma cells.
Supporting Evidence
- MYCN knockdown led to increased expression of neuronal differentiation markers NFL and GAP43.
- Induced MYCN knockdown increased the fraction of neuroblastoma cells in the G1 phase of the cell cycle.
- The clonogenic growth potential of MYCN-knockdown cells was dramatically reduced.
Takeaway
Researchers found a way to make cancer cells act more like nerve cells by turning off a specific gene that makes them grow uncontrollably.
Methodology
The study used retrovirally delivered inducible shRNA to knock down MYCN in neuroblastoma cell lines and assessed neuronal differentiation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website